https://clinicaltrials.gov/ct2/show/NCT03093480?type=Intr&cond=hemophilia&lupd_s=03%2F20%2F2019&lupd_d=14
Condition : Hemophilia A With Inhibitors
Intervention : Biological: rFVIIIFc
Sponsors : Bioverativ Therapeutics Inc.; Swedish Orphan Biovitrum
Recruiting
A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)
NCT03093480
Tue, 28 Mar 2017 12:00:00 EDT
Last Update Posted: 04/03/19 07:43AM
